Fluorescence Image Guided Foregut Surgery
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorIHU Strasbourg
About this trial
A high number of resected lymph nodes is an independent prognostic factor for improved survival after esophagectomy or gastrectomy for cancer. The quality of the lymphadenectomy is operator-dependent, as is the evaluation of the vascularization of the digestive structures that are anastomosed to restore digestive continuity after esophago-gastric resection. The aim of the study is to evaluate the impact of Indocyanine Green (ICG) and near infra-red (NIR) fluorescence imaging guidance in terms of number of lymph nodes resected and quality of gastrointestinal tract anastomoses in esophagogastric cancer surgery.
Eligibility criteria
Qualifiers
Man or woman over 18 years old.
Patient with resectable primitive esophageal or gastric cancer confirmed by biopsy without distant metastases
Patient with no contraindications to anaesthesia and performance of esophageal and/or gastric surgery
Patient able to receive and understand information related to the study and give written informed consent.
Disqualifiers
Patient undergoing emergency surgery (hemorrhage, occlusion or perforation).
Presence of distant metastasis
Patient at risk of allergy to indocyanine green or to other fluorescent compounds
Pregnant or lactating patient.
Trial design
Treatments tested in this trial
- Near Infra-Red Fluorescence Guided Surgery
Treatment groups
60 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov